SlideShare a Scribd company logo
1 of 17
Pharmaceutical Sponsor
Engagement Survey to
Improve the Protocol
Activation Process
David Akainda, Trang Bui, Jenna Burg and Morgan Celone
April 14, 2015
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
WHY IS THIS IMPORTANT?
The single most important mission for a
Comprehensive Cancer Center
is
CLINICAL CANCER RESEARCH
2
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
Our James Board Level Goal
Reduce Time to Trial to 3-4 months
for all therapeutic clinical trials
3
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
Clinical Trial Development Process
A JOURNEY
4
Basic Research
Homegrown Science
Industry Partners NCI Co-operative
Groups
PROTOCOL IS DEVELOPED
PROTOCOL APPROVAL PROCESS
PROTOCOL OPENS AND BENEFITS PATIENTS
PROTOCOL ACTIVATION PROCESS
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
Actual Response Rate Desired Response Rate
ResponseRate
Response Rate After 1st E-Mail
SURVEY COLLECTION
Response
Rate: 4/95
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
Actual Response Rate Desired Response Rate
ResponseRate
Response Rate After 2nd E-
Mail
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
Actual Response Rate Desired Response Rate
ResponseRate
Response Rate After 3rd E-
Mail
Response
Rate: 6/95
Response Rate:
13/95
Introduction email
explaining the
survey
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
DATA ANALYSIS: An overall view
Highest average:
Biggest strength
Lowest average:
Biggest weakness
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
7
1. Staff professionalism (AV 4.38)
2. Staff receptivity to the sponsor role/responsibility (AV 4.25)
3. Staff explanation of their role/responsibility (AV 4.23)
Top Three Strengths
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
1. Communication of protocol progress (AV 3.23)
2. Length of activation process (AV 3.31)
3. Timeliness of communications (AV 3.54)
8
Top Three Weaknesses
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
“Staff collaborated very well with us to activate the
protocol in a timely manner.”
“I liked that there are people specialized in roles.”
“Too many people are involved and there seems to be
very little internal communication”
9
Sponsor Comments
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
Analyze each
individual area
identified as
needing
improvement
List 6-10
suggestions
for
improvement/r
esources
needed
Use priority
scale (ease,
cost, impact)
to identify top
3 improvement
strategies
Lowest
number =
highest priority
strategy
10
IMPROVEMENT STRATEGY
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute 11
Top Recommendations
Length of Activation Process
Improvement Strategy Resources
Ease with
which to
Implement
(1 is easy)
Cost
(1 is least
expensive)
Impact on
Overall
Process (1
is high)
Priority
Scale
(AxBxC)
Have the Protocol in a
form which can be
accessible online via
computers, smart phones,
tablets etc. when
changes/updates occur
(similar to Google docs). It
enables proper handover
of crucial information and
sponsors get updated
frequently at the same
time.
Software,
IT
specialist
2 4 2 16
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute 12
Top Recommendations
Communication of Protocol Progress
Improvement Strategy Resources
Ease with
which to
Implement
(1 is easy)
Cost
(1 is least
expensive)
Impact on
Overall
Process
(1 is high)
Priority
Scale
(AxBxC)
At initial activation of
process, set up ground
rules and a weekly
conference to
communicate by email,
phone, teleconference
etc. so that both sides
know when something is
urgent and can easily
receive crucial updates.
Phone/Com
puter,
Conference
Site
2 1 1 2
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute 13
Top Recommendations
Timeliness of Communications
Improvement Strategy Resources
Ease with
which to
Implement
(1 is easy)
Cost
(1 is least
expensive)
Impact on
Overall
Process
(1 is high)
Priority
Scale
(AxBxC)
Having a direct person to
contact for all types of
communications. By
doing this roundabout
emails/calls will be
avoided and the best
person to answer all
questions/concerns will
immediately be
contacted.
Person to
Take on
Role, Chart
Containing
Contact
Information
2 1 2 4
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
Pharmaceutical Sponsor The James
• More Informed at Each Step
• Trials Opening Quicker
• Clearer Communications
• Faster Communications
• More likely to Work with The James
in the Future
• Improved Relationship with The
James
• Less Redundancies in Activation
Process
• “Experts” Trained to Answer
Questions
• Clearer Communications
• Faster Communications
• Quicker Turn Over Process
• Standardized Work Flow
• Improved Relationship with
Pharmaceutical Sponsors
14
Impact
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute 15
LESSONS LEARNED
• Limitations
• The advantages/disadvantages of table-
topping vs. speaking to stakeholders directly
• Importance of titles in communication with people
outside of the organization
• Refining the distribution sample before sending
out the survey
• Earlier introduction of the incentive during our
survey distribution
• Importance of a high survey response rate
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
NEXT STEPS
16
Present improvement strategies based off of
our prioritization to Clinical Trials Leadership
Staff to see the possibility of implementation.
NEXT STEPS
Pharmaceutical Sponsor Survey

More Related Content

What's hot

Scaling Innovation in Academic Medical Centers
Scaling Innovation in Academic Medical CentersScaling Innovation in Academic Medical Centers
Scaling Innovation in Academic Medical CentersMaulik Majmudar
 
TransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources InitiativeTransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources InitiativeTransCelerate
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Covance
 
David Haggstrom Regenstrief Conference Slides
David Haggstrom Regenstrief Conference SlidesDavid Haggstrom Regenstrief Conference Slides
David Haggstrom Regenstrief Conference SlidesShawnHoke
 
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceHow Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceSC CTSI at USC and CHLA
 
Marshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities SlidesMarshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities SlidesShawnHoke
 
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesRonan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesCirdan
 
Mulaz Bustani Regenstrief Conference Slides
Mulaz Bustani Regenstrief Conference SlidesMulaz Bustani Regenstrief Conference Slides
Mulaz Bustani Regenstrief Conference SlidesShawnHoke
 
PrEP Implementation Planning for the US
PrEP Implementation Planning for the USPrEP Implementation Planning for the US
PrEP Implementation Planning for the USCHAMP Network
 
Best Practices for a Data-driven Approach to Test Utilization
Best Practices for a Data-driven Approach to Test UtilizationBest Practices for a Data-driven Approach to Test Utilization
Best Practices for a Data-driven Approach to Test UtilizationViewics
 
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsAdvanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsViewics
 
Using alternative scholarly metrics to showcase the impact of your research: ...
Using alternative scholarly metrics to showcase the impact of your research: ...Using alternative scholarly metrics to showcase the impact of your research: ...
Using alternative scholarly metrics to showcase the impact of your research: ...SC CTSI at USC and CHLA
 
5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic
5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic
5 Reasons the Practice of Evidence-Based Medicine Is a Hot TopicHealth Catalyst
 
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsDigital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsSC CTSI at USC and CHLA
 
Patient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient OutcomesPatient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
 
Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...
Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...
Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...PrimaryCareProgress
 
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemTackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
 

What's hot (20)

Scaling Innovation in Academic Medical Centers
Scaling Innovation in Academic Medical CentersScaling Innovation in Academic Medical Centers
Scaling Innovation in Academic Medical Centers
 
TransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources InitiativeTransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources Initiative
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Advisory Panel on Clinical Trials Spring 2014 Meeting
Advisory Panel on Clinical Trials Spring 2014 MeetingAdvisory Panel on Clinical Trials Spring 2014 Meeting
Advisory Panel on Clinical Trials Spring 2014 Meeting
 
Advisory Panel on Improving Healthcare Systems Spring 2014 Meeting
Advisory Panel on Improving Healthcare Systems Spring 2014 MeetingAdvisory Panel on Improving Healthcare Systems Spring 2014 Meeting
Advisory Panel on Improving Healthcare Systems Spring 2014 Meeting
 
David Haggstrom Regenstrief Conference Slides
David Haggstrom Regenstrief Conference SlidesDavid Haggstrom Regenstrief Conference Slides
David Haggstrom Regenstrief Conference Slides
 
The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...
The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...
The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...
 
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceHow Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
 
Marshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities SlidesMarshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities Slides
 
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesRonan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
 
Mulaz Bustani Regenstrief Conference Slides
Mulaz Bustani Regenstrief Conference SlidesMulaz Bustani Regenstrief Conference Slides
Mulaz Bustani Regenstrief Conference Slides
 
PrEP Implementation Planning for the US
PrEP Implementation Planning for the USPrEP Implementation Planning for the US
PrEP Implementation Planning for the US
 
Best Practices for a Data-driven Approach to Test Utilization
Best Practices for a Data-driven Approach to Test UtilizationBest Practices for a Data-driven Approach to Test Utilization
Best Practices for a Data-driven Approach to Test Utilization
 
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsAdvanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
 
Using alternative scholarly metrics to showcase the impact of your research: ...
Using alternative scholarly metrics to showcase the impact of your research: ...Using alternative scholarly metrics to showcase the impact of your research: ...
Using alternative scholarly metrics to showcase the impact of your research: ...
 
5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic
5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic
5 Reasons the Practice of Evidence-Based Medicine Is a Hot Topic
 
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsDigital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
 
Patient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient OutcomesPatient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient Outcomes
 
Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...
Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...
Clinical Innovation Network April 2015 Webinar: Practice Transformation in Re...
 
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemTackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
 

Viewers also liked

Patient Access Network Foundation - PV Reporter
Patient Access Network Foundation - PV ReporterPatient Access Network Foundation - PV Reporter
Patient Access Network Foundation - PV ReporterDavid Wallace
 
Highlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance ProgramsHighlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance ProgramsExL Pharma
 
Iclio eCourse Navigating Patient Assistance Programs for Immunotherapy
Iclio eCourse Navigating Patient Assistance Programs for ImmunotherapyIclio eCourse Navigating Patient Assistance Programs for Immunotherapy
Iclio eCourse Navigating Patient Assistance Programs for ImmunotherapyStephanie Moore
 
Advocacy Excellence: Optimizing Group Structure & Operations Report Summary
Advocacy Excellence: Optimizing Group Structure & Operations Report SummaryAdvocacy Excellence: Optimizing Group Structure & Operations Report Summary
Advocacy Excellence: Optimizing Group Structure & Operations Report SummaryBest Practices
 
Your All Access Pass to Patient Assistance Programs
Your All Access Pass to Patient Assistance ProgramsYour All Access Pass to Patient Assistance Programs
Your All Access Pass to Patient Assistance ProgramsMedavie Blue Cross
 
Government Affairs and Public Policy Excellence Report Summary
Government Affairs and Public Policy Excellence Report SummaryGovernment Affairs and Public Policy Excellence Report Summary
Government Affairs and Public Policy Excellence Report SummaryBest Practices
 
Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...SKIM
 
Creating value through patient support programs
Creating value through patient support programsCreating value through patient support programs
Creating value through patient support programsSKIM
 
Driving Growth & Talent Retention through Pay for Performance
Driving Growth & Talent Retention through Pay for PerformanceDriving Growth & Talent Retention through Pay for Performance
Driving Growth & Talent Retention through Pay for PerformanceBest Practices
 

Viewers also liked (11)

Patient Access Network Foundation - PV Reporter
Patient Access Network Foundation - PV ReporterPatient Access Network Foundation - PV Reporter
Patient Access Network Foundation - PV Reporter
 
Highlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance ProgramsHighlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
 
oncology-marketplace
oncology-marketplaceoncology-marketplace
oncology-marketplace
 
Iclio eCourse Navigating Patient Assistance Programs for Immunotherapy
Iclio eCourse Navigating Patient Assistance Programs for ImmunotherapyIclio eCourse Navigating Patient Assistance Programs for Immunotherapy
Iclio eCourse Navigating Patient Assistance Programs for Immunotherapy
 
PCORI COI Board Webinar
PCORI COI Board WebinarPCORI COI Board Webinar
PCORI COI Board Webinar
 
Advocacy Excellence: Optimizing Group Structure & Operations Report Summary
Advocacy Excellence: Optimizing Group Structure & Operations Report SummaryAdvocacy Excellence: Optimizing Group Structure & Operations Report Summary
Advocacy Excellence: Optimizing Group Structure & Operations Report Summary
 
Your All Access Pass to Patient Assistance Programs
Your All Access Pass to Patient Assistance ProgramsYour All Access Pass to Patient Assistance Programs
Your All Access Pass to Patient Assistance Programs
 
Government Affairs and Public Policy Excellence Report Summary
Government Affairs and Public Policy Excellence Report SummaryGovernment Affairs and Public Policy Excellence Report Summary
Government Affairs and Public Policy Excellence Report Summary
 
Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...
 
Creating value through patient support programs
Creating value through patient support programsCreating value through patient support programs
Creating value through patient support programs
 
Driving Growth & Talent Retention through Pay for Performance
Driving Growth & Talent Retention through Pay for PerformanceDriving Growth & Talent Retention through Pay for Performance
Driving Growth & Talent Retention through Pay for Performance
 

Similar to Pharmaceutical Sponsor Survey

Test Utilization White Paper
Test Utilization White PaperTest Utilization White Paper
Test Utilization White PaperGary Weiland
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...MedStatix, LLC
 
PERI-Facts.11.2.11
PERI-Facts.11.2.11PERI-Facts.11.2.11
PERI-Facts.11.2.11Bob Latino
 
Clinical Trials Conduct and Protocol Compliance in Asia
Clinical Trials Conduct and Protocol Compliance in AsiaClinical Trials Conduct and Protocol Compliance in Asia
Clinical Trials Conduct and Protocol Compliance in AsiaMedpace
 
J.Curtis-Aug15CV-Final (1)
J.Curtis-Aug15CV-Final (1)J.Curtis-Aug15CV-Final (1)
J.Curtis-Aug15CV-Final (1)Jaclyn Curtis
 
Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma
Imaging Techniques for the Diagnosis and Staging of Hepatocellular CarcinomaImaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma
Imaging Techniques for the Diagnosis and Staging of Hepatocellular CarcinomaImran Javed
 
Environmental scans versus horizon scans; systematic reviews versus rapid rev...
Environmental scans versus horizon scans; systematic reviews versus rapid rev...Environmental scans versus horizon scans; systematic reviews versus rapid rev...
Environmental scans versus horizon scans; systematic reviews versus rapid rev...Kimberly Yang
 
Comparative Effectiveness Research
Comparative Effectiveness ResearchComparative Effectiveness Research
Comparative Effectiveness ResearchRick Mathis
 
best_practices_residency_program_interviews_09132016
best_practices_residency_program_interviews_09132016best_practices_residency_program_interviews_09132016
best_practices_residency_program_interviews_09132016Amy Addams
 
C4QI Survey Monkey Results
C4QI Survey Monkey ResultsC4QI Survey Monkey Results
C4QI Survey Monkey ResultsAli Casiere
 
Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...
Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...
Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...AHRQ Health Care Innovations Exchange
 

Similar to Pharmaceutical Sponsor Survey (20)

Test Utilization White Paper
Test Utilization White PaperTest Utilization White Paper
Test Utilization White Paper
 
Elite research network 2011
Elite research network   2011Elite research network   2011
Elite research network 2011
 
State of the Ohio State University Medical Center 2011
State of the Ohio State University Medical Center 2011State of the Ohio State University Medical Center 2011
State of the Ohio State University Medical Center 2011
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
 
PERI-Facts.11.2.11
PERI-Facts.11.2.11PERI-Facts.11.2.11
PERI-Facts.11.2.11
 
C. Everett Koop National Health Award Update 2014 with Ron Goetzel
C. Everett Koop National Health Award Update 2014 with Ron Goetzel C. Everett Koop National Health Award Update 2014 with Ron Goetzel
C. Everett Koop National Health Award Update 2014 with Ron Goetzel
 
Early benefits and impacts of EPR implementation
Early benefits and impacts of EPR implementationEarly benefits and impacts of EPR implementation
Early benefits and impacts of EPR implementation
 
Clinical Trials Conduct and Protocol Compliance in Asia
Clinical Trials Conduct and Protocol Compliance in AsiaClinical Trials Conduct and Protocol Compliance in Asia
Clinical Trials Conduct and Protocol Compliance in Asia
 
Establishing safety event analysis team (seat) “turned ordinary people in to ...
Establishing safety event analysis team (seat) “turned ordinary people in to ...Establishing safety event analysis team (seat) “turned ordinary people in to ...
Establishing safety event analysis team (seat) “turned ordinary people in to ...
 
J.Curtis-Aug15CV-Final (1)
J.Curtis-Aug15CV-Final (1)J.Curtis-Aug15CV-Final (1)
J.Curtis-Aug15CV-Final (1)
 
Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma
Imaging Techniques for the Diagnosis and Staging of Hepatocellular CarcinomaImaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma
Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma
 
Environmental scans versus horizon scans; systematic reviews versus rapid rev...
Environmental scans versus horizon scans; systematic reviews versus rapid rev...Environmental scans versus horizon scans; systematic reviews versus rapid rev...
Environmental scans versus horizon scans; systematic reviews versus rapid rev...
 
Agreeing what outcomes to measure
Agreeing what outcomes to measureAgreeing what outcomes to measure
Agreeing what outcomes to measure
 
Comparative Effectiveness Research
Comparative Effectiveness ResearchComparative Effectiveness Research
Comparative Effectiveness Research
 
best_practices_residency_program_interviews_09132016
best_practices_residency_program_interviews_09132016best_practices_residency_program_interviews_09132016
best_practices_residency_program_interviews_09132016
 
Patient Reported Outcomes to Accelerate Change
Patient Reported Outcomes to Accelerate ChangePatient Reported Outcomes to Accelerate Change
Patient Reported Outcomes to Accelerate Change
 
C4QI Survey Monkey Results
C4QI Survey Monkey ResultsC4QI Survey Monkey Results
C4QI Survey Monkey Results
 
2004 Cancer SOS paper
2004 Cancer SOS paper2004 Cancer SOS paper
2004 Cancer SOS paper
 
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & ValueHepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
 
Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...
Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...
Clinical-Community Relationships as a Pathway To Improve Health: Tools for Re...
 

Pharmaceutical Sponsor Survey

  • 1. Pharmaceutical Sponsor Engagement Survey to Improve the Protocol Activation Process David Akainda, Trang Bui, Jenna Burg and Morgan Celone April 14, 2015
  • 2. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute WHY IS THIS IMPORTANT? The single most important mission for a Comprehensive Cancer Center is CLINICAL CANCER RESEARCH 2
  • 3. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Our James Board Level Goal Reduce Time to Trial to 3-4 months for all therapeutic clinical trials 3
  • 4. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Clinical Trial Development Process A JOURNEY 4 Basic Research Homegrown Science Industry Partners NCI Co-operative Groups PROTOCOL IS DEVELOPED PROTOCOL APPROVAL PROCESS PROTOCOL OPENS AND BENEFITS PATIENTS PROTOCOL ACTIVATION PROCESS
  • 5. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 Actual Response Rate Desired Response Rate ResponseRate Response Rate After 1st E-Mail SURVEY COLLECTION Response Rate: 4/95 0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 Actual Response Rate Desired Response Rate ResponseRate Response Rate After 2nd E- Mail 0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 Actual Response Rate Desired Response Rate ResponseRate Response Rate After 3rd E- Mail Response Rate: 6/95 Response Rate: 13/95 Introduction email explaining the survey
  • 6. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute DATA ANALYSIS: An overall view Highest average: Biggest strength Lowest average: Biggest weakness
  • 7. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 7 1. Staff professionalism (AV 4.38) 2. Staff receptivity to the sponsor role/responsibility (AV 4.25) 3. Staff explanation of their role/responsibility (AV 4.23) Top Three Strengths
  • 8. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 1. Communication of protocol progress (AV 3.23) 2. Length of activation process (AV 3.31) 3. Timeliness of communications (AV 3.54) 8 Top Three Weaknesses
  • 9. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute “Staff collaborated very well with us to activate the protocol in a timely manner.” “I liked that there are people specialized in roles.” “Too many people are involved and there seems to be very little internal communication” 9 Sponsor Comments
  • 10. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Analyze each individual area identified as needing improvement List 6-10 suggestions for improvement/r esources needed Use priority scale (ease, cost, impact) to identify top 3 improvement strategies Lowest number = highest priority strategy 10 IMPROVEMENT STRATEGY
  • 11. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 11 Top Recommendations Length of Activation Process Improvement Strategy Resources Ease with which to Implement (1 is easy) Cost (1 is least expensive) Impact on Overall Process (1 is high) Priority Scale (AxBxC) Have the Protocol in a form which can be accessible online via computers, smart phones, tablets etc. when changes/updates occur (similar to Google docs). It enables proper handover of crucial information and sponsors get updated frequently at the same time. Software, IT specialist 2 4 2 16
  • 12. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 12 Top Recommendations Communication of Protocol Progress Improvement Strategy Resources Ease with which to Implement (1 is easy) Cost (1 is least expensive) Impact on Overall Process (1 is high) Priority Scale (AxBxC) At initial activation of process, set up ground rules and a weekly conference to communicate by email, phone, teleconference etc. so that both sides know when something is urgent and can easily receive crucial updates. Phone/Com puter, Conference Site 2 1 1 2
  • 13. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 13 Top Recommendations Timeliness of Communications Improvement Strategy Resources Ease with which to Implement (1 is easy) Cost (1 is least expensive) Impact on Overall Process (1 is high) Priority Scale (AxBxC) Having a direct person to contact for all types of communications. By doing this roundabout emails/calls will be avoided and the best person to answer all questions/concerns will immediately be contacted. Person to Take on Role, Chart Containing Contact Information 2 1 2 4
  • 14. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Pharmaceutical Sponsor The James • More Informed at Each Step • Trials Opening Quicker • Clearer Communications • Faster Communications • More likely to Work with The James in the Future • Improved Relationship with The James • Less Redundancies in Activation Process • “Experts” Trained to Answer Questions • Clearer Communications • Faster Communications • Quicker Turn Over Process • Standardized Work Flow • Improved Relationship with Pharmaceutical Sponsors 14 Impact
  • 15. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 15 LESSONS LEARNED • Limitations • The advantages/disadvantages of table- topping vs. speaking to stakeholders directly • Importance of titles in communication with people outside of the organization • Refining the distribution sample before sending out the survey • Earlier introduction of the incentive during our survey distribution • Importance of a high survey response rate
  • 16. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute NEXT STEPS 16 Present improvement strategies based off of our prioritization to Clinical Trials Leadership Staff to see the possibility of implementation. NEXT STEPS

Editor's Notes

  1. On behalf of Suhas and I, we want to thank everyone for the help with this project. We truly appreciate the opportunity to learn and gain insight on the process that chemotherapy research patients encounter at the James.